Opinion · 28 Feb 2025
Conference abstractPublished 2018
Current and future trends in QconCATs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Protein quantification by targeted proteomics relies on mass spectrometry and isotope-labeled internal standards. In addition to traditional standards comprised of either recombinant proteins or synthetic peptides, artificial proteins composed of concatenated peptides (Q conCATs) have been introduced as a conceptually new material for use as an internal standard. The design, ex-pression, characterization and some application of Q conCATs have been thoroughly described in the set of original papers from Beynon’s laboratory. The focus of this presentation is to describe two new trends in the use of Q conCATs as internal standards: (i) the need of natural flanking sequences for every Q-peptide included in the Q conCAT and (ii) the benefits of stoichiometric incorporation of post-translational modifications in the Q conCAT. These developments in Q conCATs have not received much attention so far, but show great promise for future advances in targeted proteomics. On the application side, the focus of this presentation is on expression of various protein isoforms that can be indicative of pathological changes associated with Alzheimer’s disease. Selective quantification of individual protein isoforms has been always a challenge, because they simultaneously possess common and unique amino acid sequences. We developed a Q conCAT for quantification of various isoforms of amyloid precursor protein (APP). APP-Q conCAT includes tryptic peptides that are common for all isoforms of APP concatenated with those tryptic peptides that are unique for specific APP isoforms. Isotope-labeled APP-Q conCAT was expressed, purified, characterized and further used for quantifica-tion of total APP, APP695, APP305, and amyloid-β in the human frontal cortex from control and severe Alzheimer’s disease donors. Potential biological implications of our quantitative meas-urements are discussed.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Dec 2024
Evaluating the Clinical Efficacy of Novel Drug Candidates: Current Trends and Future Directions
Short communication · 30 Sep 2024
Viral Vector-Based Vaccines: Current Trends and Future Prospects
Opinion · 12 Sep 2024
Transforming Drug Delivery with Phytochemical Solutions: Current Trends and Future Directions
Article · 29 Jan 2024
Targeted Drug Delivery Systems for Cancer Therapy Current Trends and Future Directions
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
The Intersection of Drug Research and Environmental Impact
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sergey Suchkov”
- BylineArticles whose byline prints “Illarion V Turko”

